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ABSTRACT 25 
Background: Most guidelines recommend at least two cm excision margin for melanomas 26 
thicker than two mm.  27 
Objective: We evaluated whether one or two cm excision margins for melanoma (> 2 mm) 28 
result in different outcomes. 29 
Methods: This is a retrospective cohort study on patients with melanomas (> 2 mm) who 30 
underwent tumor excision with one cm (228 patients) or two cm (97 patients) margins to 31 
investigate presence of local recurrences, locoregional and distant metastases, disease-free 32 
and overall survival. 33 
Results: Three hundred twenty-five patients with mean age of 61.84 years and Breslow 34 
thickness of 4.36 mm, were considered for the study with a median follow-up of 1852 days 35 
(1995- 2012). There was no significant difference in the frequency of locoregional and 36 
distant metastasis between the two groups (P = 0.311, 0.571). The survival analysis 37 
showed no differences for disease-free (P = 0.800; HR, 0.948; 95% CI 0.627 to 1.433) and 38 
overall-survival (P = 0.951; HR, 1.018; 95% CI 0.575 to 1.803). 39 
Limitations: The study was not prospectively randomized. 40 
Conclusions: Our study did not show any significant differences in important outcome 41 
parameters like local- or distant metastases, overall survival. A prospective study testing 42 
one versus two cm excision margin is warranted.  43 
Key words Disease free survival; Margin of excision; Melanomas thicker than 2 mm; 44 
Metastases; Overall survival; Recurrences   45 
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INTRODUCTION 46 
One of the major controversies in the primary management of melanoma is how much 47 
surrounding normal skin should be excised around a primary cutaneous melanoma.1-4 48 
Balancing cosmesis, function and morbidity with oncologic outcomes requires careful 49 
decision-making with respect to determination of the appropriate margins.5 Inadequate 50 
excision margins increase the risk of local recurrence.6 Conversely, unnecessarily large 51 
margins of excision generate greater morbidity and increased costs.4 Overall survival, 52 
disease-free survival, and local recurrence rates are not improved by excision margins 53 
greater two cm.7 Therefore, a two cm excision margin is recommended for melanomas 54 
thicker than two mm in most clinical guidelines.4,7  55 
In our clinics a 1cm excision margin is the approved standard by the regional Melanoma 56 
Board for melanoma thicker than two mm, whereas external consultants operated with a 57 
two cm excision margin. We now analyzed in a retrospective study over a period of 16-58 
years whether 1 cm surgical excision margin has caused any disadvantages in important 59 
outcome parameters, in comparison to two cm margins.  60 
 61 
  62 
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METHODS 63 
Study Population 64 
We performed a population-based survey of melanoma management (registered in 65 
ClinicalTrials.gov, trial number NCT02088762) using a database of patients from the Bern 66 
University Hospital. The study period ranged from May 1995 to May 2012, with follow-up 67 
until the end of July 2013. All cases of single, primary, localized, cutaneous melanoma 68 
tumors with > two mm thickness without evidence of metastasis at the time of surgery and 69 
treated by excision of the lesion were included in the study. Patients without documented 70 
surgical margins or follow-up were excluded. This study was conducted in accordance 71 
with the standards of the Ethical Committee of the Canton of Bern (KEK number: 24-08-72 
10) on human experimentation and with the Helsinki Declaration of 1975, as revised in 73 
1983.  74 
 75 
Procedures 76 
We collected data on patient gender, age, tumor location, tumor type, Breslow thickness, 77 
and presence of ulceration, distant and locoregional metastases. All surgeons were board 78 
certified and accredited members of an established cancer cooperative group. 79 
During the 17-year time period, two consultants performed primary melanoma excision 80 
according to the current accepted guidelines, using a 2 cm margin (two cm group). All 81 
other consultants excised all melanoma in accordance with our regional Melanoma Board 82 
approved guideline with a one cm margin irrespective of Breslow thickness (one cm 83 
group). Thus, the excision margins were dependent on the referral to the individual 84 
consultant. In all cases, sentinel lymph node biopsies were taken. An experienced 85 
pathologist from the University Hospital Bern reviewed the excised tissues and the slides 86 
were also evaluated by a panel of melanoma pathologists, who independently reviewed a 87 
representative histologic section of each.  88 
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In the current study, local recurrences can represent either persistent disease due to 89 
inadequate initial excision or true recurrence adjacent to the scar after adequate prior wide 90 
local excision and usually have an in situ component, or they may represent satellite 91 
metastases. Locoregional recurrence of melanoma after initial resection was defined as 92 
recurrence at the site of the primary lesion, regionally in the draining lymph node basin, or 93 
anywhere in between (local recurrence cases were not included).8-10 Spreading from the 94 
original (primary) tumor to distant organs or distant lymph nodes was considered as distant 95 
metastases.11 96 
Local recurrence rates, locoregional and distant metastases, death attributed to melanoma, 97 
disease-free survival, and overall survival were compared between the two groups.  98 
 99 
Statistical Analysis 100 
All analyses were conducted using the Statistics Package for the Social Sciences (spss; 101 
SPSS Inc., Chicago, IL, USA) version 21.0. All p values relate to two-sided tests with an 102 
alpha level of 0.05. For categorical patient characteristics, Fisher’s exact test was used to 103 
detect differences between groups. Disease-free survival was estimated using the Kaplan-104 
Meier method. The confidence intervals of hazard ratios for Cox regression and overall 105 
survival (for time-to-event variables) were calculated. P value was based on the Log Rank 106 
(Mantel-Cox) test to check whether the two groups had different overall survival functions. 107 
P value < 0.05 was considered significant. 108 
 109 
  110 
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RESULTS 111 
Of all patients with malignant melanoma treated in our center between May 1995 and May 112 
2012, 325 (138 female, 187 male) patients with melanoma thicker than 2 mm with a 113 
median age of 61.84± 14.71 years (mean ± SD) fulfilled the inclusion criteria (Fig 1). The 114 
median follow-up for the patients was 1852 days. The mean ± SD Breslow’s depth of the 115 
study patients’ primary melanoma tumors was 4.36 ± 3.99 mm (2.10 – 45.00 mm). Two 116 
hundred twenty lesions (67.7 %) revealed an infiltration thickness≤ four mm, while 105 117 
(32.3 %) were thicker than four mm. Nodular melanoma was the most frequent (68.3 %) 118 
and amelanotic melanoma the least frequent (1.8 %) type in our study population. 119 
Furthermore, the trunk area was the most frequent primary tumor location (39.4%). One 120 
hundred forty patients (43.1 %) had ulceration in their tumors, 106 patients (32.6 %) 121 
presented with positive sentinel lymph node biopsies, and death was attributable to 122 
melanoma in 54 patients (16.6%). 123 
Two hundred twenty eight patients underwent tumor excision with a one cm skin margin 124 
while the tumors of the other 97 patients were excised with a two cm margin. 125 
Statistical analysis of tumor characteristics (tumor thickness, primary tumor location, 126 
tumor type, and sentinel lymph node metastasis) did not reveal significant differences 127 
between the two groups, except for ulceration, which was detected significantly more often 128 
in the one cm group (Table 1).  129 
Local recurrence occurred in 11 patients (3.4 %), locoregional metastases in 74 patients 130 
(22.8 %) and distant metastases in 77 (23.7 %). Although ulceration was seen more 131 
frequently in the one cm group, this did not result in a significant difference in local 132 
recurrence (P = 0.739), locoregional (P = 0.311) and distant metastases (P = 0.571) during 133 
the follow-up period. Death attributable to melanoma was also not significantly different 134 
between our study groups (18.8 % vs. 18.6 %, respectively) (Table 2). 135 
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Kaplan-Meier methods comparing disease-free and overall survival did not reveal a 136 
significant difference between the one cm group and the two cm group (P = 0.800 and 137 
0.951, respectively). In Cox regression analysis of the patients with one cm excision 138 
margins vs. the patients with two cm excision margins, the estimated hazard ratios for 139 
disease-free survival and overall survival were 0.948 (95% confidence interval, 0.627 to 140 
1.433) and 1.018 (95% confidence interval, 0.575 to 1.803), respectively (Tables 3, Fig 2-141 
3). 142 
 143 
  144 
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DISCUSSION 145 
Guidelines for melanoma treatment emphasize the importance of complete surgical 146 
excision.12-15 However, selection of an adequate excision margin is one of the major 147 
controversies in the management of primary cutaneous melanomas, especially in 148 
melanoma thicker than two mm.1, 3, 4 In light of the tendency to narrow the excision 149 
margins in primary melanoma thicker than two mm treatment, Gillgren, P et al. performed 150 
a randomized controlled trial in this patient group that compared a two cm versus a four cm 151 
surgical resection margin. Their findings suggested that a two cm resection margin is 152 
sufficient and safe for patients with cutaneous melanoma thicker than two mm.3 As a 153 
result, currently, most protocols suggest at least a two cm excision margin for melanoma > 154 
two mm in depth.16-18 155 
In order to follow this way to have a narrower but safe excision margins in primary 156 
melanoma treatment, we retrospectively analyzed the outcome of patients with melanomas 157 
thicker than two mm (2.10 – 45.00 mm in thickness) using a one or a two cm excision 158 
margin. Although our study was not prospectively randomized, the two study population 159 
were balanced for important prognostic factors with the exception of ulceration, which was 160 
more frequent in the group with narrower excision margin (Table 1). In this study, we did 161 
not detect a statistically significant increase in locoregional metastases, distant metastases 162 
or a decrease in disease-free or overall survival in patients undergoing a resection with 163 
only 1 cm margin.  164 
We observed more locoregional and distant metastases in the patients with two cm 165 
excision margins, but these differences were not statistically significant. Similarly, 166 
Gillgren et al. reported less distant metastasis in the group with narrower excision margins 167 
( two cm) versus the wider excision (four cm).  This difference might raise the idea that 168 
selection of wider excision margins may increase the risk of locoregional and distant 169 
metastases. 170 
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Gillgren et al. reported that 14.53% of patients died by melanoma,3 while death attributable 171 
to melanoma was seen in 16.6 % of our patients, which was not significantly different 172 
between the groups in our study (P = 0.625). Thomas et al. reported deaths in 28.26% of 173 
the group with 1 cm margins and 23.49 % of the group with 3 cm margins.4 Moreover, 174 
Thomas et al. found a significant increase in the risk of death from melanoma associated 175 
with a narrow margin of excision in comparison to a wide margin after evaluation of their 176 
results and Swedish Melanoma Study Group trial (P = 0.008).4, 19 177 
Furthermore, Kaplan-Meier methods and Cox regression analysis of our groups showed no 178 
evidence of significant differences in disease-free survival and overall survival. Likewise, 179 
in Thomas et al.’s study on high-risk melanoma, a similar overall survival rate (P = 0.6; 180 
HR, 1.07; 95% confidence interval 0.85 to 1.36) was reported between the groups with 1 181 
cm and 3 cm excision margins. Nevertheless, due to the increased risk of melanoma related 182 
death in the group with narrow excision margins, the authors concluded that the use of a 183 
one cm margin should be avoided in patients with melanomas ≥ 2 mm thickness.4 184 
In summary, despite various studies, clear evidence that increasing excision margins 185 
improves overall-survival is currently missing.16 Furthermore, decision about the need for 186 
two cm margins for thicker melanomas is still an important controversy. As a result there is 187 
a demand for further studies to overcome these issues. We believe that modification of 188 
current approved guidelines which are based on important clinical studies should be only 189 
performed carefully after implementation of prospective randomised multicenteric clinical 190 
trials. However, despite several limitations (being retrospective, and non-randomized, and 191 
having relative short follow-up), the result of the current study suggests that excision of 192 
melanomas thicker than two mm with one cm excision margin is safe and results in a 193 
similar outcome as a two cm excision margin. Therefore, this study highlights the possible 194 
hope for future, and may provoke the important melanoma centers to set up new 195 
randomized controlled trials with longer follow-up to revise current melanoma guidelines.  196 
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Figure: 254 
 255 
Fig. 1. Patient disposition 256 
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 257 
Fig. 2. Disease-free survival according to primary melanoma site (log-rank test, P = 0.800). 258 
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 259 
Fig. 3. Overall survival (log-rank test, P = 0.951)  260 
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Tables: 262 
TABLE 1. Study patients’ characteristics 263 
Characteristics Margin of surgery P 
1 cm 2 cm 
Mean follow-up in years 5.18 5.51 0.207 
Tumour thickness [Breslow] (Mean ± SD mm) 4.22 ± 2.81 4.67 ± 5.90 0.479 
Sex 
No. of Female patients 
(percent) 
98 (42.98%) 40 (41.24%) 0.807 
 
No. of Male Patients 
(percent) 
130 (57.02%) 57 (58.76%) 
Primary tumour 
location 
No. (percent) 
 
Head and neck 47 (20.61%) 11 (11.34%) 0.119 
 Trunk 82 (35.96%) 46 (47.42%) 
Upper extremity 44 (19.30%) 16 (16.49%) 
Lower extremity 55 (24.12%) 24 (24.74%) 
Tumour type 
No. (percent) 
Nodular melanoma 148 (64.91%) 74 (76.29%) 0.190 
 
 
 
 
Superficial spreading 
melanoma 
52 (22.81%) 16 (16.49%) 
Acral lentiginous melanoma 9 (3.95%) 5 (5.15%) 
Lentigo maligna melanoma 7 (3.07%) 0 (0.00%) 
Desmoplastic melanoma 7 (3.07%) 1 (1.03%) 
Amelanotic melanoma 5 (2.19%) 1 (1.03%) 
Positive sentinel 
lymph node biopsy  
No. of positive result 
(percent) 
68 (29.82%) 38 (39.17%) 0.121 
Ulceration No. of positive result 
(percent) 
108 (47.37%) 32 (32.98%) 0.020 
 264 
 265 
 266 
 267 
 268 
 269 
 270 
 271 
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TABLE 2. Study patients’ follow-up characteristics 272 
Characteristics 
 
Margin of surgery Exact Sig. (2-
sided) 
1 cm 2 cm 
Local recurrence, (percent) 7(3.07%) 4(4.12%) 0.739 
Locoregional metastases, (percent) 48(21.05%) 26(26.80%) 0.311 
Distant metastases, (percent) 52 (22.81%) 25 (25.77%) 0.571 
Death attributed to melanoma, (percent) 36 (15.79%) 18 (18.56%) 0.625 
 273 
 274 
 275 
TABLE 3. Means for disease free survival and overall survival Time 276 
Margin Mean
a for DFS Time Means for OS Time 
Estimate Std. 
Error 
95% Confidence 
Interval 
Estimate Std. 
Error 
95% Confidence Interval 
Lower 
Bound 
Upper 
Bound 
Lower Bound Upper 
Bound 
1cm 3289.17 157.72 2980.03 3598.31 4150.41 125.75 3903.94 4396.89 
2cm 2139.09 110.38 1922.76 2355.43 2551.48 76.19 2402.134 2700.82 
Overall 3253.04 135.34 2987.78 3518.30 4085.29 111.62 3866.50 4304.07 
 277 
 278 
